World is running out of antibiotics: WHO

Drugs currently in the clinical pipeline are mostly the modifications of existing classes of antibiotics and are only short-term solutions

GN Bureau | September 20, 2017


#World Health Organisation   #WHO   #Health   #Antibiotics  
Representational image
Representational image

There is going to be a huge lack of new antibiotics in coming future. A report by the World Health Organisation (WHO) has revealed that there is “a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.”

The report called Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis was released on Wednesday.

According to the report, drugs currently in the clinical pipeline are mostly the modifications of existing classes of antibiotics and are only short-term solutions. The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250 000 people each year.

Director general, WHO, Dr Tedros Adhanom Ghebreyesus has termed antimicrobial resistance as a global health emergency. "There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB, otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery,” he said in an official statement.

WHO has identified 12 classes of priority pathogens, some of them causing common infections such as pneumonia or urinary tract infections, that are increasingly resistant to existing antibiotics and urgently in need of new treatments.

“There is a serious lack of treatment options for multidrug- and extensively drug-resistant M. tuberculosis and gram-negative pathogens, including Acinetobacter and Enterobacteriaceae (such as Klebsiella and E.coli) which can cause severe and often deadly infections that pose a particular threat in hospitals and nursing homes,” the report said.

"Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days because we have no line of defence," says Dr Suzanne Hill, Director of the Department of Essential Medicines at WHO.

Comments

 

Other News

Is BharatNet digging too deep?

India’s ambition to become a digitally empowered society rests on the premise that every citizen, regardless of geography, should have access to reliable and affordable internet. At the heart of this mission is BharatNet, a flagship programme launched by the government of India to provide high-speed

WAVES Summit: A Global Media Powerhouse

In 2019, at the inauguration of National Museum of Indian Cinema, prime minister Narendra Modi had expressed his wish to have a forum of global repute similar to the World Economic Forum, Davos, for India’s media and entertainment (M&E) industry. That wish became reality with the WAVES Summit in

India’s silent lead crisis

Flint, Michigan, was a wake-up call. Lead contamination in water supplied to homes in that American city led to a catastrophic public health emergency in 2014, which is yet to be fully resolved. But India’s lead poisoning crisis is ten times worse- larger, quieter, and far most devastating. Nearly ha

‘Dial 100’: A tribute to the police force and its unsung heroes

Dial 100  By Kulpreet Yadav HarperCollins, 232 pages, Rs 299  A wife conspires with her ex-lover to mur

India’s economic duality: formal dreams, informal realities

“Whatever you can rightly say about India, the opposite is also true.” – Joan Robinson In its pursuit of becoming a $5 trillion economy, India has laid significant emphasis on formalizing its economic architecture—expanding digital payments, mandating

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter